Restraining Network Response to Targeted Cancer Therapies Improves Efficacy and Reduces Cellular Resistance
Crossref DOI link: https://doi.org/10.1158/0008-5472.CAN-17-2001
Published Online: 2018-07-31
Published Print: 2018-08-01
Update policy: https://doi.org/10.1158/crossmark_policy
Das, Tirtha K.
Esernio, Jessica
Cagan, Ross L.
Funding for this research was provided by:
NIH (R01-CA170495)
NIH (R01-CA109730)
Department of Defense (W81XWH-15-1-0111)
American Cancer Society (120616-RSGM-11-018-01-CDD)
American Cancer Society (120886-PFM-11-137-01-DDC)
